| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.049 | 0.3 |